Drug Database
Back to search

Netherlands· NL-09a7a534a621

Palonosetron Accord 250 microgram oplossing voor injectie

A palonosetron product containing palonosetronhydrochloride, registered in Netherlands by Accord Healthcare S.L.U.. The same ATC class is registered in 18 of our 19 countries.

ATC A04AA05

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPalonosetron Accord 250 microgram opl…ATCA04AA05REGISTER NO.NL-09a7a534a621PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about palonosetronhydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Palonosetron is registered in 18 of 19 countries.

Countries holding a registration under ATC A04AA05 (palonosetron), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 10 of them publish a price we can compare per daily dose
Search palonosetron products by name

Palonosetron · ATC A04AA05

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Palonosetron · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$124.11
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PALONOSETRONHYDROCHLORIDE
Manufacturer
Accord Healthcare S.L.U.
Country
Netherlands (NL)
ATC code
A04AA05
ATC class
Palonosetron
Defined daily dose
0.5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/16/1104

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

490 interactions on record for palonosetron.

Graded by severity as the source publishes them — 139 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check palonosetron against other medicinesHow interaction checks work

Palonosetron · interactions on record

490 records

  • 139 severe
  • 195 moderate
  • 3 minor
  • 153 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • FenfluramineA08AA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Palonosetron in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palonosetron products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Palonosetron Kalceks
  • Belgium · Palonosetron Fresenius Kabi, Palonosetron Juta
  • Bulgaria · Ферант
  • Cyprus · Ferant, Injosetron
  • Czechia · Ferant, Palonosetron Fresenius Kabi
  • Germany · Palonosetron Beta, Palonosetron Fresenius Kabi
  • Denmark · Palonosetron Kalceks, Palonosetron Macure
  • Estonia · Ferant, Palonosetron Kalceks
  • Spain · Ferant, Palonosetrón Qilu
  • Finland · Palonosetron Fresenius Kabi, Palonosetron Macure
  • France · Palonosetron Kalceks, Palonosetron Reig Jofre
  • United Kingdom (Northern Ireland) · Palonosetron Fresenius Kabi, Palonosetron Hydrochloride Qilu Pharma Spain
  • Greece · Ferant, Injosetron
  • Croatia · Ferant, Palonozetron Kalceks
  • Hungary · Palonosetron Kalceks, Palonosetron Onkogen
  • Ireland · Palonosetron
  • Iceland · Aloxi, Palonosetron Accord
  • Italy · Palonosetron Dr. Reddy’s, Palonosetron Fresenius Kabi
  • Liechtenstein · Aloxi, Palonosetron Accord
  • Lithuania · Ferant
  • Latvia · Ferant, Palonosetron Kalceks
  • Malta · Ferant, Palonosetron Anfarm
  • Norway · Aloxi, Palonosetron Accord
  • Portugal · Ferant, Palanossetrom Fresenius Kabi
  • Romania · Ferant, Palonosetron Dr. Reddy’s
  • Sweden · Ferant, Palonosetron Fresenius Kabi
  • Slovenia · Ferant, Palonosetron Fresenius Kabi
  • Slovakia · Ferant, Palonosetron Fresenius Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f6173a04-5336-4835-82da-dec04accebb0
GET /v1/drugs/f6173a04-5336-4835-82da-dec04accebb0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/palonosetron-accord-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Palonosetron",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp117541",
  "excipients": [
    "CITROENZUUR 1-WATER (E 330)",
    "DINATRIUMEDETAAT 2-WATER",
    "MANNITOL (D-) (E 421)",
    "NATRIUMHYDROXIDE (E 524)",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "PALONOSETRONHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2016/05/26",
  "procedure_number": "EMEA/H/C/004129",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/16/1104",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about palonosetron.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console